Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand

Source

Nature Communications, 12(1).

Authors

Huang, Q. S., Wood, T., Jelley, L., Jennings, T., Jefferies, S., Daniells, K., Nesdale, A; Dowell, T., Turner, N.; Campbell-Stokes, P.; Balm, M.; Dobinson, H. C.; Grant, C. C.; James, S.; Aminisani, N.; Ralston, J.; Gunn, W.; Bocacao, J.; Danielewicz, J.; Moncrieff, T.; McNeill, A.; Lopez, L.; Waite, B.; Kiedrzynski, T.; Schrader, H.; Gray, R.; Cook, K.; Currin, D.; Engelbrecht, C.; Tapurau, W.; Emmerton, L.; Martin, M.; Baker, M. G.; Taylor, S.; Trenholme, A.; Wong, C.; Lawrence, S.; McArthur, C.; Stanley, A.; Roberts, S.; Rahnama, F.; Bennett, J.; Mansell, C.; Dilcher, M.; Werno, A.; Grant, J.; van der Linden, A.; Youngblood, B.; Thomas, P. G. & Webby, R. J.

Department

Health Science

Abstract

Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.

view journal

What can we help you find today?

Suggested keywords

Expertise

Digital library

People